
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GAP-43 CRISPR/Cas9 KO Plasmid (m) | sc-420484 | 20 µg | $397.00 |
Gap43 encodes growth associated protein 43 (GAP-43), a neuron-enriched, membrane-associated phosphoprotein that localizes to growth cones and presynaptic terminals where it regulates neurite outgrowth, axon guidance, and synaptic remodeling. GAP-43 function is tightly linked to actin cytoskeleton dynamics and calcium-dependent signaling, including PKC-mediated phosphorylation that modulates membrane interactions and plasticity-associated processes. In mouse, Gap43 expression increases during development and after neural injury, making it a widely used molecular marker of axonal growth and regenerative responses. Dysregulated GAP-43–dependent circuitry remodeling has been associated with altered synaptic connectivity in models of neurodevelopmental and neurodegenerative disorders, supporting its relevance for mechanistic studies of neuronal network function.
GAP-43 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Gap43 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Gap43 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Gap43 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish GAP-43 protein expression.
This CRISPR knockout system enables efficient generation of Gap43-deficient cell models for investigation of GAP-43 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.